Fig. 2From: Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practiceOutcome analysis. Results of Cox regression on primary and secondary outcomes in the AT (a) and ITT (b) dataset. Event rates are reported as number of events/1000 person-yearsBack to article page